Trial of Intravenous Immune Globulin in Dermatomyositis.
Aggarwal R, Charles-Schoeman C, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis C, Schiopu E, Vencovský J, Beckmann I, Clodi E, Bugrova O, Dankó K, Ernste F, Goyal NA, Heuer M, Hudson M, Hussain YM, Karam C, Magnolo N, Nelson R, Pozur N, Prystupa L, Sárdy M, Valenzuela G, van der Kooi AJ, Vu T, Worm M, Levine T; ProDERM Trial Group.
N Engl J Med. 2022 Oct 6;387(14):1264-1278. doi: 10.1056/NEJMoa2117912.
Intravenous Immune Globulin Therapy in Dermatomyositis.
Amato AA.
N Engl J Med. 2022 Oct 6;387(14):1320-1321. doi: 10.1056/NEJMe2209117.
A New Intravenous Immune Globulin: Novel or Not?
Bates BN, Olah ME.
Ann Pharmacother. 2021 Jan;55(1):117-122. doi: 10.1177/1060028020934722. Epub 2020 Jun 21.
Trial of Intravenous Immune Globulin in Dermatomyositis.
Werth VP, Fiorentino DF, Vleugels RA.
N Engl J Med. 2023 Jan 5;388(1):94. doi: 10.1056/NEJMc2214285.
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.
Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Latov N, Merkies IS, van Doorn PA; ICE Study Group.
Lancet Neurol. 2008 Feb;7(2):136-44. doi: 10.1016/S1474-4422(07)70329-0.
Intravenous immune globulin in primary immunodeficiency.
Haeney M.
Clin Exp Immunol. 1994 Jul;97 Suppl 1(Suppl 1):11-5.
Intravenous immune globulin in autoimmune and inflammatory diseases.
Gelfand EW.
N Engl J Med. 2012 Nov 22;367(21):2015-25. doi: 10.1056/NEJMra1009433.
Trial of Intravenous Immune Globulin in Dermatomyositis. Reply.
Aggarwal R, Charles-Schoeman C, Schessl J.
N Engl J Med. 2023 Jan 5;388(1):94-95. doi: 10.1056/NEJMc2214285.
Intravenous immune globulin in recurrent abortion.
Heine O, Mueller-Eckhardt G.
Clin Exp Immunol. 1994 Jul;97 Suppl 1(Suppl 1):39-42.
Intravenous immune globulin in myasthenia gravis.
Gajdos P.
Clin Exp Immunol. 1994 Jul;97 Suppl 1(Suppl 1):49-51.
